Tag Archives: Candida albicans

MMA (mixed martial arts) and nano silver wound dressings

I had never, ever expected to mention mixed martial arts (MMA) here but that’s one of the delightful aspects of writing about nanotechnology; you never know where it will take you. A March 9, 2015 news item on Azonano describes the wound situation for athletes and a new product,

..

As an MMA Champion athlete, Rich Franklin knows all too well about germs and how easily they spread. During training he dealt with them on a regular basis, but it wasn’t until the first time he had staph, did he realize these infections could cost him a victory. Now, working in a global setting, Franklin trains in locations around the world which leaves him exposed to a plethora of bacteria and fungi. So he teamed up with American Biotech Labs (ABL) to develop Armor Gel, nano silver-based, wound dressing gel that can stay active on the skin for up to seventy-two hours (3 days). Using patented nano silver technology, Armor Gel has been scientifically tested to reduce the levels of bacteria and other pathogens, while forming a protective barrier “armor” over the wound. By shielding the body from external bacterial, the body’s natural healing process can be expedited. Its use is recommended by doctors, trainers, coaches, and athletes alike.

A March 6, 2015 ABL news release on BusinessWire, which originated the news item, provides a little more detail about Armor Gel,

Engineered for today’s modern athletes, Armor Gel is safe, nontoxic and provides a personal first line of defense. Already proven to reduce the levels of MRSA, VRE, pseudomonas aeruginosa, E. coli, A. niger and Candida albicans, Armor Gel is formulated using a unique and patented 24 SilverSol Technology®.

American Biotech Labs (ABL) was started in 2002 as a nano silver biotech company with the goal of creating a more stable and powerful silver technology for consumer products. …

I am providing a link to the product website (neither the link nor this post are endorsements), you can find out more about Armor Gel here.

Armor Gel was announced previously in a Sept. 16, 2014 ABL news release on PR Newswire, At the time no mention was made of Rich Franklin, their MMA athlete,

American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products.  The new products will allow American Biotech Labs (ABL) to market in the wound-care market focusing on ultimate sports and fitness, spa and health, and animal markets.

The new over-the-counter (OTC) products will have wound-dressing claims for minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations.  The products also have pathogen-inhibiting barrier claims against pathogens, such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, MRSA and VRE, as well as fungi, such as Candida albicans and Aspergillus niger.  These new gels can provide a barrier that will help protect wounds for 24 to 72 hours.

The new products will be found under the names of Armor Gel™ (for the ultimate sports and fitness market), ASAP OTC™ (for the spa and health markets), and ASAP Pet Shield® (for the animal market).

Along with the release of these new products, ABL has formed a strategic alliance with Stuart Evey, founder and former chairman of ESPN, and Gary Bernstein, marketing executive and professional photographer and film maker.  ABL will utilize these talented individuals to help introduce these revolutionary new products to high-profile organizations in sports, pet stores, fashion and beauty, medical, and direct-marketing areas, etc.

Said Keith Moeller, ABL Director, “We are very grateful to the numerous top scientists, labs and universities that have helped move this amazing, patented, silver technology forward.  We believe that these products have the ability to impact the future of wound management worldwide.”

Note: Any statements released by American Biotech Labs, LLC that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company’s business prospects and performance.

You can find out more about ABL and its entire product line here.

Fungal infections, begone!

A May 7, 2014 news item on Nanowerk highlights some antifungal research at A*STAR (Singapore’s Agency for Science, Technology and Research),

Pathogenic fungi like Candida albicans can cause oral, skin, nail and genital infections. While exposure to pathogenic fungi is generally not life-threatening, it can be deadly to immunocompromised patients with AIDS or cancer. A variety of antifungal medications, such as triazoles and polyenes, are currently used for treating fungal infections. The range of these antifungal medications, however, is extremely limited, with some fungal species developing resistance to these drugs.

Yi Yan Yang at the A*STAR Institute of Bioengineering and Nanotechnology in Singapore and co-workers, in collaboration with IBM Almaden Research Center in the United States, have discovered four cationic terephthalamide-bisurea compounds with strong antifungal activity, excellent microbial selectivity and low host toxicity …

A May 7, 2018 A*STAR news release, which originated the news item, describes the research in detail (Note: A link has been removed),

Conformational analysis revealed that the terephthalamide-bisurea compounds have a Z-shaped structure: the terephthalamide sits in the middle, urea groups on both sides of the terephthalamide, and cationic charges at both ends. The researchers prepared compounds with different spacers — ethyl, butyl, hexyl or benzyl amine — in-between the urea group and the cationic charge.

When dissolved in water, the terephthalamide-bisurea compounds aggregate to form fibers with lengths ranging from a few hundred nanometers to several micrometers. Some of the compounds form fibers with high flexibility and others with high rigidity.

The researchers evaluated the antifungal activity of their terephthalamide-bisurea compounds against C. albicans. They found that all of the cationic compounds effectively inhibited fungal growth, even when the fungal concentration increased from 102 to 105 colony-forming units per milliliter.

The researchers believe that the potent antifungal activity is largely due to the formation of fibers with extremely small diameters in the order of 5 to 10 nanometers, which facilitates the rupture of fungal membranes. “This is particularly important because the fungal membrane of C. albicans is multilayered and has low negative charges,” explains Yang. “It also helps explain why cationic terephthalamide-bisurea compounds could easily penetrate the fungal membrane.”

The terephthalamide-bisurea compounds also eradicated clinically isolated drug-resistant C. albicans. The compounds prevent the development of drug resistance by rupturing the fungal membrane of C. albicans and disrupting the biofilm (see image).

Additionally, cytotoxicity tests showed that the cationic terephthalamide-bisurea compounds exhibit low toxicity toward mammalian cells and in a mouse model, revealing that the compounds “are relatively safe for preventing and treating fungal infections,” says Yang. [emphasis mine]

It’s nice to see that this potential anti-fungal treatment isn’t damaging to one’s cells.

Here’s a link to and a citation for the paper,

Supramolecular high-aspect ratio assemblies with strong antifungal activity by Kazuki Fukushima, Shaoqiong Liu, Hong Wu, Amanda C. Engler, Daniel J. Coady, Hareem Maune, Jed Pitera, Alshakim Nelson, Nikken Wiradharma, Shrinivas Venkataraman, Yuan Huang, Weimin Fan, Jackie Y. Ying, Yi Yan Yang, & James L. Hedrick. Nature Communications 4, Article number: 286 doi:10.1038/ncomms3861 Published 09 December 2013

This article is behind a paywall.

Could nanoparticles in your mouthwash affect for your cells?

The first news item I’m going to highlight was posted on Nanowerk, March 8, 2012 and is focused on the use of silver nanoparticles in mouthwashes and dentures to prevent yeast infections,

Yeasts which cause hard-to-treat mouth infections are killed using silver nanoparticles in the laboratory, scientists have found. These yeast infections, caused by Candida albicans and Candida glabrata target the young, old and immuno-compromised. Professor Mariana Henriques, University of Minho [Portugal], and her colleagues hope to test silver nanoparticles in mouthwash and dentures as a potential preventative measure against these infections.

Professor Henriques and her team, who published their research in the Society for Applied Microbiology’s journal Letters in Applied Microbiology(“Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms”), looked at the use of different sizes of silver nanoparticles to determine their anti-fungal properties …

The scientists used artificial biofilms in conditions which mimic those of saliva as closely as possible. They then added different sizes and concentrations of silver nanoparticles and found that different sizes of nanoparticles were equally effective at killing the yeasts. Due to the diversity of the sizes of nanoparticles demonstrating anti-fungal properties the researchers hope this will enable the nanoparticles to be used in many different applications.

Some researchers have expressed concerns around the safety of nanoparticle use but the authors stress this research is at an early stage and extensive safety trials will be carried out before any product reaches the market. [emphasis mine]

Following on the notion of safety and gargling silver nanoparticles, coincidentally, there was another news item also dated March 8, 2012 on Nanowerk, this one about the impact that nanoparticles may have on nutrient uptake,

Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology (“Oral exposure to polystyrene nanoparticles affects iron absorption”). These tiny particles, even in low doses, could have a big impact on our long-term health.

According to lead author of the article, Gretchen Mahler, assistant professor of bioengineering at Binghamton University, much of the existing research on the safety of nanoparticles has been on the direct health effects. But what Mahler, Michael L. Shuler of Cornell University and a team of researchers really wanted to know was what happens when someone gets constant exposure in small doses – the kind you’d get if you were taken a drug or supplement that included nanoparticles in some form. [e.g. silver nanoparticles in your mouthwash or on your dentures]

“We thought that the best way to measure the more subtle effects of this kind of intake was to monitor the reaction of intestinal cells,” said Mahler. “And we did this in two ways: in vitro, through human intestinal-lining cells that we had cultured in the lab; and in vivo, through the intestinal linings of live chickens. Both sets of results pointed to the same thing – that exposure to nanoparticles influences the absorption of nutrients into the bloodstream.”

As for why the researchers focused on iron and tested polystyrene nanoparticles (from the news item),

The uptake of iron, an essential nutrient, was of particular interest due to the way it is absorbed and processed through the intestines. The way Mahler and the team tested this was to use polystyrene nanoparticles because of its easily traceable fluorescent properties.

“What we found was that for brief exposures, iron absorption dropped by about 50 percent,” said Mahler. “But when we extended that period of time, absorption actually increased by about 200 percent. It was very clear – nanoparticles definitely affects iron uptake and transport.”

While acute oral exposure caused disruptions to intestinal iron transport, chronic exposure caused a remodeling of the intestinal villi – the tiny, finger-like projections that are vital to the intestine’s ability to absorb nutrients – making them larger and broader, thus allowing iron to enter the bloodstream much faster.

As to whether these changes are good or bad the researchers don’t speculate. They do have plans for more testing,

calcium,
copper,
zinc, and
fat-soluble vitamins A, D, E and K

They don’t mention any changes in the types of nanoparticles they might be testing in future.

In any event, our bodies have changed a lot over the centuries, you just have to visit a pyramid in Egypt or a museum that holds medieval armour to observe that humans were once much shorter than we are today.